The relative valuations conducted in this article suggest that Cytek presents an undervaluation in the range of 16.43% to 109 ...

EML’s balance sheet is showing recovery from prior stretched levels. December 2024's gearing (interest-bearing borrowings/equity) ratio sits at 29%, down from 57% in June 2024 and 56% in June 2023.